Two fibroblast growth factor (FGF) receptor substrates (FRS2 and FRS3) are involved in downstream signaling from activated FGF receptors and neurotrophin-activated Trk receptors. Despite the importance of signaling from these factors in embryogenesis, FRS2 and FRS3 expression patterns during development are unknown. In this study we characterize the expression of FRS2 and FRS3 from E7 to parturition and in adult murine tissues. Both are first detected in whole E8.5 CD1 mouse embryos. FRS2 is detected as early as E7 in the developing syncytiotrophoblast, later in the neural tube (NT) and in many adult and fetal tissues. FRS3 is more restricted in location than FRS2 (fetal NT, heart, stomach, liver and some adult tissues), and is expressed predominantly in the ventricular layer of the developing NT and brains of murine embryos.
We report the cloning and partial sequences of two novel bovine tissue‐specific alkaline phosphatase (AP) isozymes (TSAP2 and TSAP3) from in vitro–produced bovine blastocysts. Using a reverse‐transcribed polymerase chain reaction (RT‐PCR)–based assay for mRNA expression and in vitro–produced preattachment bovine embryos, TSAP2 mRNA was detected first at the four‐cell stage prior to the major burst of embryonic transcription in cattle and TSAP3 at the eight‐cell stage with the major burst in transcription. Furthermore, the transcription of TSAP2 and TSAP3 displays a curious “on‐off” pattern during early cleavages between 40 and 120 hr after insemination. Activity of bovine AP, measured by an azo‐dye coupling technique, indicates that at least one AP isozyme is functional in oocytes and embryos throughout bovine preattachment development. However, maternal and embryonic‐derived AP activity may have different cell‐surface distributions. This novel expression pattern of the bovine AP isozymes could provide a useful tool for identifying and clarifying the events controlling transcription and gene expression during early embryo development. Mol. Reprod. Dev. 50:7–17, 1998. © 1998 Wiley‐Liss, Inc.
The alkaline phosphatases are a small family of isozymes. Bovine preattachment embryos transcribe mRNA for two tissue-specific alkaline phosphatases (TSAP2 and TSAP3) beginning at the 4- and 8-cell stages. Whereas no mRNA has been detected in oocytes, there is maternally inherited alkaline phosphatase activity. It is not known which isozyme(s) is responsible for the maternal activity or when TSAP2 and TSAP3 form functional protein. No antibodies are available that recognize the relevant bovine alkaline phosphatases. Therefore, sensitivity to heat and chemical inhibition was used to separate the different isozymes. By screening tissues, it was determined that the bovine tissue-nonspecific alkaline phosphatase (TNAP) is inactivated by low temperatures (65C) and low concentrations of levamisole (<1 mM), whereas bovine tissue-specific isozymes require higher temperatures (90C) and levamisole concentrations (>5 mM). Inhibition by L-homoarginine and L-phenylalanine was less informative. Cumulus cells transcribe two isozymes and the pattern of inhibition suggested heterodimer formation. Inhibition of alkaline phosphatase in bovine embryos before the 8-cell stage indicated the presence of only TNAP. At the 16-cell stage the pattern was consistent with TNAP plus TSAP2 or -3 activity, and in morulae and blastocysts the pattern indicated that the maternal TNAP is fully supplanted by TSAP2 or TSAP3.
The signaling adapter proteins FRS2 and FRS3 are implicated in the transmission of extracellular signals from nerve growth factor (NGF) or fibroblast growth factor (FGF) receptors to the Ras/mitogen-activated protein kinase signaling cascade. This study presents the genomic sequence and exon-intron organization of the mouse FRS2 and FRS3 loci as well as their evolutionary conservation with their human counterparts. Both FRS2 and FRS3 contain 5 coding exons spanning over 7 kb of genomic sequence with similar exon sizes and organization. Comparative genomic sequence analyses show a highly conserved genomic organization between mouse and human in both FRS2 and FRS3 genes. Non-coding sequences, highly conserved between mouse and human, were identified in the FRS3 introns that may potentially function as regulatory elements. To assay potential differences in their patterns of expression, RT-PCR analysis was used to assay FRS2 and FRS3 expression in the developing embryo and neural tube (NT) during the time of neurogenesis.
The mechanisms of zona pellucida (ZP) loss in peri-implantation hamster embryos in vivo versus in vitro are distinctly different. To investigate if ZP loss in vivo is the result of transient uterine pH changes, the luminal pH of the pregnant uterus was measured during the ZP loss period. Prior to ZP loss, pH was 7.30 +/- 0.05 (mean +/- SE; left uterine horn) and 7.35 +/- 0.03 (right horn). During ZP loss, pH was 7.26 +/- 0.07 (left) and 7.35 +/- 0.03 (right), and after embryo attachment, 7.25 +/- 0.02 (left) and 7.27 +/- 0.02 (right). None of these values are statistically different. The pseudopregnant uterine pH was 7.30 +/- 0.04 (left) and 7.31 +/- 0.04 (right), not statistically different from each other or from pregnant uteri. Blastocyst ZP loss in vitro (pH 3.0-8.5) occurred only at pH 3.0. Loss of ZP occurred in uterine flushings from pregnant or pseudopregnant hamsters, evidence that ZP loss is related to uterine factors. Complete ZP loss occurred at pH 6.8, but was incomplete at pH 6.6, 7.0 and 7.2. No ZP loss occurred in uterine flushings from non-mated females. In summary: (i) a change in uterine pH does not cause ZP loss in vivo in the Syrian hamster; (ii) a pH-sensitive factor in pregnant and pseudopregnant uterine fluid is responsible for ZP loss.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.